Skip to main content
Log in

Plasma myeloperoxidase activity as a criterion of therapeutic effectiveness for patients with cardiovascular diseases

  • Published:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

A significant increase in the myeloperoxidase (MPO) activity has been found in plasma of patients with stable angina and with acute coronary syndrome (ACS) in comparison with the control group. MPO concentration was significantly increased in plasma of ACS patients. Reduced MPO activity in the treated ACS patients correlated with a favorable outcome of the disease. Generally, changes in plasma MPO concentration coincided with changes in lactoferrin concentration thus confirming the role of neutrophil degranulation in the increase of plasma concentrations of these proteins. The increase in MPO activity was obviously determined by modification of the MPO protein caused by reactive oxygen species and halogen in the molar ratio of 1: 25 and 1: 50. The decrease in plasma MPO activity may be associated with increased plasma concentrations of the physiological inhibitor of its activity, ceruloplasmin, and also with modification of the MPO protein with reactive oxygen species and halogen at their molar ratio of 1: 100 and higher. Thus, MPO activity may be used for evaluation of effectiveness of the treatment of cardiovascular diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ACS:

acute coronary syndrome

ELISA:

enzyme linked immunosorbent assay

IHD:

ischemic heart disease

MI:

myocardial infarction

MPO:

myeloperoxidase

References

  1. Schindhelm, R.K., van der Zwan, L.P., Teerlink, T., and Scheffer, P.G., Clinical Chemistry, 2009, vol. 55, pp. 1462–1470. doi 10.173/clinchem.2009.126029

    Article  CAS  Google Scholar 

  2. Nicholls, S.J. and Hazen, S.L., Arteriosclerosis, Thrombosis, and Vascular Biology, 2005, vol. 25, pp. 1102–1111.

    Article  CAS  Google Scholar 

  3. Samygina, V.R., Sokolov, A.V., Bourenkov, G., Petoukhov, M.V., Pulina, M.O., Zakharova, E.T., Vasilyev, V.B., Bartunik, H., and Svergun, D.I., PLoS One, 2013, vol. 8, p. e67145. doi 10.1371/journal.pone.0067145

    Article  CAS  Google Scholar 

  4. Sokolov, A.V., Zakahrova, E.T., Kostevich, V.A., Samygina, V.R., and Vasilyev, V.B., Biometals, 2014, vol. 27, pp. 815–828. doi 10.1007/s10534-014-9755-2

    Article  CAS  Google Scholar 

  5. Tang, W.H., Wu, Y., Hartiala, J., Fan, Y., Stewart, A.F., Roberts, R., McPherson, R., Fox, P.L., Allayee, H., and Hazen, S.L., Arteriosclerosis, Thrombosis, and Vascular Biology, 2012, vol. 32, no. 2, pp. 516–522. doi 10.1161/ATVBAHA.111.237040

    Article  Google Scholar 

  6. Wu, A.H., Clinical Chemistry, 2009, vol. 55, no. 1, pp. 12–14. doi 10.1373/clinchem.2008.118208.

    Article  CAS  Google Scholar 

  7. Zhang, R., Brennan, M.L., Fu, X., Aviles, R.J., Pearce, G.L., Penn, M.S., Topol, E.J., Sprecher, D.L., and Hazen, S.L., J. Amer. Med. Assoc., 2001, vol. 286, pp. 2136–2142.

    Article  CAS  Google Scholar 

  8. Morrow, D.A., Sabatine, M.S., Brennan, M.-L., de Lemos, J., Murphy, S.A., Ruff, C.T., Cannon, C.P., and Hazen, S.L., European Heart J., 2008, vol. 29, no. 9, pp. 1096–1102.

    Article  CAS  Google Scholar 

  9. Brennan, M.L., Penn, M.S., van Lente, F., Nambi, V., Shishehbor, M.H., Aviles, R.J., Goormastic, M., Pepoy, M.L., McErlean, E.S., Topol, E.J., Nissen, S.E., and Hazen, S.L., N. Engl. J. Med., 2003, vol. 349, pp. 1595–1604.

    Article  CAS  Google Scholar 

  10. Zhang, R., Shen, Z., Nauseef, W.M., and Hazen, S.L., Blood, 2002, vol. 99, pp. 1802–1810.

    CAS  Google Scholar 

  11. Castellani, L.W., Chang, J.J., Wang, X., Lusis, A.J., and Reynolds, W.F., J. Lipid Res., 2006, vol. 47, pp. 1366–1377.

    Article  CAS  Google Scholar 

  12. van der Veen, B.S., de Winther, M.P., and Heeringa, P., Antioxidants & Redox Signaling, 2009, vol. 11, pp. 2899–2939. doi 10.1089/ARS.2009.2538

    Article  Google Scholar 

  13. Sokolov, A.V., Ageeva, K.V., Cherkalina, O.S., Pulina M.O., Zakharova, E.T., Prozorovskii, V.N., Aksenov, D.V., Vasilyev, V.B., and Panasenko, O.M., Chemistry and Physics of Lipids, 2010, vol. 163, nos. 4-5, pp. 347–355. doi 10.1016/j.chemphyslip. 2010.02.002

    Article  CAS  Google Scholar 

  14. Sokolov, A.V., Kostevich, V.A., Kozlov, S.O., Donskyi, I.S., Vlasova, I.I., Rudenko, A.O., Zakharova, E.T., Vasilyev, V.B., and Panasenko, O.M. Free Radic. Res., 2015, vol. 49, pp. 777–789.

    Article  CAS  Google Scholar 

  15. Gorudko, I.V., Cherkalina, O.S., Sokolov, A.V., Pulina,M.O., Zakharova, E.T., Vasilyev, V.B., Cherenkevich, S.N., and Panasenko, O.M., Bioorgan. Khim., 2009, vol. 35, pp. 629–639.

    CAS  Google Scholar 

  16. Ravin, H.A., J. Lab. Clin. Med., 1961, vol. 58, pp. 161–168.

    CAS  Google Scholar 

  17. Dominguez-Rodriguez, A. and Abreu-Gonzalez, P., Exp. Rev. Cardiovasc. Ther., 2011, vol. 9, no. 2, pp. 223–230. doi 10.1586/ERC.11.2

    Article  CAS  Google Scholar 

  18. Sokolov, A.V., Kostevich, V.A., Zakharova, E.T., Samygina, V.R., Panasenko, O.M., and Vasilyev, V.B., Free Radical Res., 2015, vol. 49, no. 6, pp. 800–811. doi 10.3109/10715762.2015.1005615

    Article  CAS  Google Scholar 

  19. Panasenko, O.M., Chekanov, A.V., Vlasova, I.I., Sokolov, A.V., Ageeva, K.V., Pulina, M.O., Cherkalina, O.S., and Vasilyev, V.B., Biofizika, 2008, vol. 53, pp. 573–581.

    CAS  Google Scholar 

  20. Sokolov, A.V., Ageeva, K.V., Pulina, M.O., Cherkalina, O.S., Samygina, V.R., Vlasova, I.I., Panasenko, O.M., Zakharova, E.T., and Vasilyev, V.B., Free Radical Res., 2008, vol. 42, nos. 11–12, pp. 989–998. doi 10.1080/10715760802566574

    Article  CAS  Google Scholar 

  21. Panasenko, O.M., Gorudko, I.V., and Sokolov, A.V., Biochemistry (Moscow), 2013, vol. 78, pp. 1466–1489.

    CAS  Google Scholar 

  22. García-Montoya, I.A., Cendón, T.S., Arévalo-Gallegos, S., and Rascón-Cruz, Q., Biochim. Biophys. Acta, 2012, vol. 1820, pp. 226–236. doi 10.1016/j.bbagen.2011.06.018

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. M. Panasenko.

Additional information

Original Russian Text © D.V. Grigorieva, I.V. Gorudko, V.A. Kostevich, A.V. Sokolov, I.V. Buko, V.B. Vasilyev, L.Z. Polonetsky, O.M. Panasenko, S.N. Cherenkevich, 2016, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grigorieva, D.V., Gorudko, I.V., Kostevich, V.A. et al. Plasma myeloperoxidase activity as a criterion of therapeutic effectiveness for patients with cardiovascular diseases. Biochem. Moscow Suppl. Ser. B 10, 173–179 (2016). https://doi.org/10.1134/S1990750816020050

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750816020050

Keywords

Navigation